Search Results - F. Bijou
- Showing 1 - 4 results of 4
-
1
S205: ZANUBRUTINIB + OBINUTUZUMAB (ZO) VS OBINUTUZUMAB (O) MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF THE PHASE 2... by P. L. Zinzani, J. Mayer, R. Auer, F. Bijou, A. C. de Oliveira, C. R. Flowers, M. Merli, K. Bouabdallah, P. S. Ganly, Y. Song, H. Zhang, R. Johnson, A. M García-Sancho, M. Provencio, M. Trněný, S. Yuen, H. Tilly, E. Kingsley, G. Tuyman, S. E. Assouline, E. Ivanova, P. Kim, J. Huang, R. Delarue, J. Trotman
Published in HemaSphere (2022-06-01)Get full text
Article -
2
P1162: ZANUBRUTINIB IN OLDER PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): SUBGROUP ANALYSIS OF THE MAGNOLIA STUDY by S. Opat, B. Hu, A. Tedeschi, K. M. Linton, P. McKay, H. Chan, J. Jin, M. Sun, M. Sobieraj-Teague, P. L. Zinzani, M. Coleman, P. Browett, X. Ke, C. A. Portell, C. Thieblemont, K. Ardeshna, F. Bijou, P. Walker, E. A. Hawkes, S.-J. Ho, K.-S. Zhou, M. Co, J. Xu, Z. Liang, J. Anderson, C. Tankersley, J. Huang, J. Trotman
Published in HemaSphere (2022-06-01)Get full text
Article -
3
P1186: A LARGE FRENCH REAL WORLD MULTICENTRIC PROSPECTIVE COHORT OF PATIENTS WITH LYMPHOMA (REALYSA STUDY): DESCRIPTION OF THE DIFFUSE LARGE B CELL LYMPHOMA PATIENTS IN REAL WORLD... by H. Ghesquieres, F. Cherblanc, A. Belot, V. Camus, K. Thokagevistk, K.-K. Bouabdallah, C. Esnault, L.-M. Fornecker, S. Micon, F. Bijou, C. Haioun, N. Morineau, L. Ysebaert, G. Damaj, S. Le Gouill, S. Guidez, F. Morschhauser, C. Thiéblemont, A. Chauchet, R. Gressin, F. Jardin, C. Fruchart, G. Labouré, L. Fouillet, P. Lionne-Huyghe, A. Bonnet, L. Lebras, S. Amorim, C. Leyronnas, G. Olivier, R. Guieze, T. Lamy, V. Launay, B. Drenou, O. Fitoussi, L. Detourmignies, J. Abraham, C. Soussain, F. Lachenal, P. Fogarty, P. Cony-Makhoul, A. Bernier, S. Le Guyader-Peyrou, A. Monnereau, F. Boissard, C. Rossi
Published in HemaSphere (2022-06-01)Get full text
Article -
4
P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE II... by G. Cartron, MD, PhD, E. Bachy, MD, PhD, H. Tilly, MD, N. Daguindau, MD, G.-M. Pica, MD, F. Bijou, MD, C. Mounier, MD, A. M. Clavert, MD, G. L. Damaj, MD, PhD, B. Slama, MD, O. Casasnovas, MD, R. Houot, MD, PhD, K. Bouabdallah, MD, D. Sibon, MD, PhD, O. Fitoussi, MD, N. Morineau, MD, C. Herbaux, MD, PhD, T. Gastinne, MD, L.-M. Fornecker, MD, C. Haioun, MD, PhD, V. Launay, MD, C. Araujo, MD, O. Benbrahim, MD, L. Sanhes, MD, R. Gressin, MD, H. Gonzalez, MD, F. Morschhauser, MD, PhD, L. Xerri, MD, PhD, K. Tarte, PhD, D. Pranger, MD
Published in HemaSphere (2022-06-01)Get full text
Article
